TABLE 1.
Strains used in this study
| Strain | Capsule type | Phenotype | Relevant characteristic(s) | Reference or source |
|---|---|---|---|---|
| D39 | 2 | D39 | Mouse-passaged clinical isolate | 24 |
| AL2 | 2 | D39 LytA− | Defined autolysin-deficient lytA mutant of D39; Emr | 4 |
| PLN | 2 | D30 Ply− | Defined pneumolysin-deficient ply mutant of D39; Emr | 6 |
| WU2 | 3 | WU2 | Mouse-passaged clinical isolate | 9 |
| SM121.10 | 3 | WU2 LytA− | Defined autolysin-deficient lytA mutant of WU2; Emr | This study |
| SM321.1 | 3 | WU2 LytA− | Defined autolysin-deficient lytA mutant of WU2; Emr | This study |
| SM122.2 | 3 | WU2 LytA− | Defined autolysin-deficient lytA mutant of WU2; Emr | This study |
| UB2271 | 3 | WU2 Ply− | Defined pneumolysin-deficient ply mutant of WU2; Emr | This study |
| UB1122 | 3 | WU2 Ply− | Defined pneumolysin-deficient ply mutant of WU2; Emr | This study |
| UB1129 | 3 | WU2 Ply− | Defined pneumolysin-deficient ply mutant of WU2; Emr | This study |